设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

副总编辑:魏永祥、张运、

罗毅、谭学瑞、唐来坤、

王喜艳

编辑部主任:杨秋

邮发代号:80-528
定价:20.00元
全年:240.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2019 年第 4 期 第 14 卷

丁苯酞联合阿替普酶治疗急性缺血性脑卒中的临床效果及对患者血清炎性因子及神经递质水平的影响

Effect of butylphthalide combined with alteplase on acute ischemic stroke, serum inflammatory factors and neurotransmitters

作者:赵洁朴翔宇吴悦

英文作者:

单位:116001大连大学附属中山医院神经内一科(赵洁、朴翔宇),骨科(吴悦)

英文单位:

关键词:急性缺血性脑卒中;丁苯酞;阿替普酶;炎性因子;神经递质

英文关键词:

  • 摘要:
  • 【摘要】目的    探讨丁苯酞联合阿替普酶治疗急性缺血性脑卒中的临床效果及对患者血清炎性因子及神经递质水平的影响。方法    选取2015年5月至2018年3月大连大学附属中山医院收治的急性缺血性脑卒中患者95例为研究对象。采用前瞻性研究的方法,完全随机分为观察组(48例)和对照组(47例)。在常规治疗基础上,对照组给予阿替普酶静脉溶栓治疗,观察组给予丁苯酞静脉滴注联合阿替普酶治疗。治疗2周后,比较2组患者美国国立卫生研究院卒中量表(NIHSS)评分、临床疗效、炎性因子和神经递质水平、不良反应等指标。结果    治疗2周后,2组NIHSS评分均低于治疗前,且观察组低于对照组[(6.2±1.0)分比(9.2±1.2)分],差异均有统计学意义(均P<0.01)。观察组总有效率明显高于对照组[93.8%(45/48)比78.7%(37/47)],差异有统计学意义(P<0.05)。治疗2周后,观察组患者血清白细胞介素2、白细胞介素6、C反应蛋白、肿瘤坏死因子α水平明显低于对照组(均P<0.01),血清5-羟色胺、多巴胺含量明显高于对照组(P<0.05或P<0.01),谷氨酸、天冬氨酸含量明显低于对照组(P<0.05或P<0.01)。结论    丁苯酞联合阿替普酶有助于缓解缺血性脑卒中患者神经功能缺损程度,提高临床疗效,可能与抑制炎症反应、调节神经递质水平等因素有关。

  • 【Abstract】Objective    To explore the effect of butylphthalide combined with alteplase on acute ischemic stroke, serum inflammatory factors and neurotransmitters. Methods    A total of 95 patients with acute ischemic stroke were prospectively enrolled from May 2015 to March 2018 in Affiliated Zhongshan Hospital of Dalin University. They were randomly divided into observation group(n=48) and control group(n=47). On the basis of conventional treatments, the control group had alteplase intravenous thrombolysis; the observation group had intravenous administration of butyphthalide combined with alteplase. After 2 weeks of treatment, National Institutes of Health Stroke Scale(NIHSS) score, clinical efficacy, inflammatory factors, neurotransmitters and adverse reactions were analyzed. Results    After treatment, NIHSS score significantly decreased and the score in the observation group was lower than that in the control group[(6.2±1.0) vs (9.2±1.2)](P<0.01). Clinical effective rate in the observation group was significantly higher than that in the control group[93.8%(45/48) vs 78.7%(37/47)](P<0.05). Serum levels of interleukin-2, interleukin-6, C-reactive protein and tumor necrosis factor-α in the observation group were significantly lower than those in the control group(P<0.01). Serum levels of 5-hydroxytryptamine and dopamine in the observation group were significantly higher while glutamate and aspartate levels were lower than those in the control group(P<0.05 or P<0.01). Conclusion    Butyphthalide combined with alteplase helps to alleviate neurological deficit of ischemic stroke patient and improve the clinical efficacy, which may be related to inhibiting inflammatory response and regulating neurotransmitter level.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备18043517号-1
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭